Therefore, the above analysis of the relationship between T-lymphocyte subsets and major clinical features suggests that, as immune indicators, CD4+ and CD8+ T-lymphocyte content and CD4+/CD8+ ratio are significant predictors of the clinical features of CRC. This evidence concerns the gene CD8A and colorectal carcinoma.